BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9631404)

  • 1. Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study.
    Phoenix J; Hopkins P; Bartram C; Beynon RJ; Quinlivan RC; Edwards RH
    Neuromuscul Disord; 1998 May; 8(3-4):210-2. PubMed ID: 9631404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
    Beynon RJ; Bartram C; Hopkins P; Toescu V; Gibson H; Phoenix J; Edwards RH
    Muscle Nerve Suppl; 1995; 3():S18-22. PubMed ID: 7603521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
    Quinlivan R; Beynon RJ
    Cochrane Database Syst Rev; 2004; (3):CD003458. PubMed ID: 15266486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise induced muscle weakness in a young adult: McArdle's disease unusual presentation.
    Kalsoom H; Mukhtar H; Latif RK
    J Pak Med Assoc; 2023 Dec; 73(12):2473-2475. PubMed ID: 38083936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. McArdle's disease with non-insulin-dependent diabetes mellitus: the beneficial effects of hyperglycemia and hyperinsulinemia for exercise intolerance.
    Yamauchi A; Amano K; Ichikawa Y; Nakamoto S; Takei I; Maruyama H; Kono N; Saruta T
    Intern Med; 1996 May; 35(5):403-6. PubMed ID: 8797056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
    Vissing J; Haller RG
    N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unforeseen cardiac involvement in McArdle's disease.
    Moustafa S; Patton DJ; Connelly MS
    Heart Lung Circ; 2013 Sep; 22(9):769-71. PubMed ID: 23337261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Massive rhabdomyolysis revealing a McArdle disease].
    Loupy A; Pouchot J; Hertig A; Bonnard G; Bouvard E; Rondeau E
    Rev Med Interne; 2007 Jul; 28(7):501-3. PubMed ID: 17383055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low muscle levels of pyridoxine in McArdle's syndrome.
    Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
    Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-tetanic mechanical tension and evoked action potentials in McArdle's disease.
    Brandt NJ; Buchthal F; Ebbesen F; Kamieniecka Z; Krarup C
    J Neurol Neurosurg Psychiatry; 1977 Sep; 40(9):920-5. PubMed ID: 271684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise tolerance and daily life in McArdle's disease.
    Ollivier K; Hogrel JY; Gomez-Merino D; Romero NB; Laforêt P; Eymard B; Portero P
    Muscle Nerve; 2005 May; 31(5):637-41. PubMed ID: 15614801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?
    Lucia A; Maté-Muñoz JL; Pérez M; Foster C; Gutiérrez-Rivas E; Arenas J
    Muscle Nerve; 2007 Jan; 35(1):125-8. PubMed ID: 16967472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. McArdle's disease: two clinical expressions in the same pedigree.
    Papadimitriou A; Manta P; Divari R; Karabetsos A; Papadimitriou E; Bresolin N
    J Neurol; 1990 Jul; 237(4):267-70. PubMed ID: 2391551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot-glucagon in the treatment of McArdle's disease.
    Day TJ; Mastaglia FL
    Aust N Z J Med; 1985 Dec; 15(6):748-50. PubMed ID: 3869441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of the exercise-induced increase in muscle perfusion in McArdle's disease.
    Jehenson P; Leroy-Willig A; de Kerviler E; Merlet P; Duboc D; Syrota A
    Eur J Nucl Med; 1995 Nov; 22(11):1256-60. PubMed ID: 8575473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise to exhaustion in the second-wind phase of exercise in a case of McArdle's disease with and without creatine supplementation.
    O'Reilly DS; Carter R; Bell E; Hinnie J; Galloway PJ
    Scott Med J; 2003 May; 48(2):46-8. PubMed ID: 12774595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene sodium does influence the second-wind phenomenon in McArdle's disease. Electrophysiological evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients.
    Poels PJ; Braakhekke JP; Joosten EM; Stegeman DF
    J Neurol Sci; 1990 Dec; 100(1-2):108-12. PubMed ID: 2089128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
    Vorgerd M; Zange J
    Acta Myol; 2007 Jul; 26(1):61-3. PubMed ID: 17915573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [McArdle's disease without typical symptoms].
    Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.